Lilly psoriasis drug fares well in late-stage test

August 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

The Indianapolis-based company announced initial results from the research on Thursday and said it plans to submit the drug, ixekizumab, to regulators in the first half of next year. The drugmaker has been pushing to develop new treatments to replace revenue lost due to a wave of patent expirations that have hit top-selling drugs like the antidepressant Cymbalta.

In the ixekizumab research, between 31% and 41% of the patients taking its drug achieved clear skin, according to the drugmaker. Overall, those on the drug achieved better levels of skin clearance than patients taking a fake treatment or etanercept, which goes by the brand name Enbrel and is sold by Amgen Inc. and Pfizer Inc.

Psoriasis is a chronic disease that occurs when a person's immune system speeds up the growth cycle of skin cells. The most common form, plaque psoriasis, creates raised, red patches on the skin.

Explore further: Stimulating a protein in skin cells could improve psoriasis symptoms

Related Stories

Stimulating a protein in skin cells could improve psoriasis symptoms

June 5, 2014
Psoriasis is a common, long-lasting disease that causes itchy or sore patches of thick, red skin with silvery scales. Environmental contaminants can trigger psoriasis and other autoimmune disorders, and it is thought that ...

Skin care tips for psoriasis patients

August 25, 2013
(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an ...

FDA approves new drug for rare genetic disease

August 19, 2014
The Food and Drug Administration has approved a new capsule-based drug to treat Gaucher's disease.

AstraZeneca says DOJ closes probe into drug trial

August 19, 2014
British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Eli Lilly 2013 profit forecast tops expectations

January 4, 2013
(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.

New target for psoriasis treatment discovered

February 12, 2014
Researchers at King's College London have identified a new gene (PIM1), which could be an effective target for innovative treatments and therapies for the human autoimmune disease, psoriasis.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.